Patent: 6,300,332
✉ Email this page to a colleague
Summary for Patent: 6,300,332
Title: | Methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
Abstract: | A method of reducing, treating or preventing drug-mediated respiratory depression, muscle rigidity, or nausea/vomiting in an animal, incident to the administration to said animal of a mixed delta/mu opioid agonist or a respiratory depression-mediating drug, comprising administering to the animal receiving said drug an effective amount of a delta receptor agonist compound. |
Inventor(s): | Chang; Kwen-Jen (Chapel Hill, NC), McNutt, Jr.; Robert W. (Durham, NC), Pettit; Hugh O. (Cary, NC), Bishop; Michael J. (Durham, NC) |
Assignee: | Delta Pharmaceuticals, Inc. (Durham, NC) |
Application Number: | 09/352,308 |
Patent Claims: | see list of patent claims |
Details for Patent 6,300,332
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2012-02-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |